Membrane traffic and actin cytoskeleton dynamics are intimately linked, and GTPases of the Rho and ARF families may work together to regulate both. Recent studies have identified a family of GTPase activating proteins (GAPs) that contain both ARF-GAP and Rho-GAP domains, providing the first direct link between these two signaling pathways. Like other ARF-GAPs, ARAP1, ARAP2 and ARAP3 each contain several ankyrin repeats immediately carboxy-terminal to the ARF-GAP domain, and these repeats may function in protein-protein interactions (Figure 1 ). These proteins also have several important structural differences. First, ARAP2 and ARAP3 contain an additional amino-terminal protein interaction module, a sterile-α α motif (SAM), which is lacking in ARAP1. Second, sequence analysis predicts the presence of a Ras-interacting domain in ARAP1 that is absent in ARAP2 and ARAP3. Whether ARAP1 interacts with Ras directly remains to be determined. Third, ARAP2 contains a unique region with homology to the switch 2 domain of the small GTPase Rab13. Finally, and importantly, the Rho-GAP domain of ARAP2 lacks the key catalytic arginine residue found in most GAPs (the so-called 'arginine finger') and is therefore unlikely to possess Rho-GAP activity. Although ARAP2 has not been characterized further, ARAP1 and ARAP3 have important functional differences. ARAP1 displayed a clear substrate preference for ARF1 and ARF5 in vitro, whereas ARAP3 appeared to be specific for ARF6. Similarly, ARAP1 Rho GAP activity was directed primarily towards RhoA, while ARAP3 used RhoA, Rac1 or Cdc42 without preference [15,16].
both Rho and ARF GTPases. Until recently, these proteins could be divided into two classes, each possessing either Rho-GAP or ARF-GAP activity, but not both. However, the laboratories of Paul Randazzo [15] and Phillip Hawkins [16] have now identified three new proteins, ARAP1, ARAP2 and ARAP3, that each contain both ARF-GAP and Rho-GAP domains (Figure 1 ).
An additional feature of these proteins is the presence of five pleckstrin homology (PH) domains. These domains typically mediate the interaction of proteins with phosphoinositides and, in fact, ARAP3 was isolated on the basis of its affinity for immobilized PtdIns(3,4,5)P 3 [16] . ARAP3 binds to PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 with high affinity via its amino-terminal PH domain [16] . Consistent with this binding specificity, the ARF-GAP activity of both ARAP1 and ARAP3 is dependent upon the presence of PtdIns(3,4,5)P 3 or PtdIns(3,4)P 2 [ Like other ARF-GAPs, ARAP1, ARAP2 and ARAP3 each contain several ankyrin repeats immediately carboxy-terminal to the ARF-GAP domain, and these repeats may function in protein-protein interactions ( Figure 1 ). These proteins also have several important structural differences. First, ARAP2 and ARAP3 contain an additional amino-terminal protein interaction module, a sterile-α α motif (SAM), which is lacking in ARAP1. Second, sequence analysis predicts the presence of a Ras-interacting domain in ARAP1 that is absent in ARAP2 and ARAP3. Whether ARAP1 interacts with Ras directly remains to be determined. Third, ARAP2 contains a unique region with homology to the switch 2 domain of the small GTPase Rab13. Finally, and importantly, the Rho-GAP domain of ARAP2 lacks the key catalytic arginine residue found in most GAPs (the so-called 'arginine finger') and is therefore unlikely to possess Rho-GAP activity. Although ARAP2 has not been characterized further, ARAP1 and ARAP3 have important functional differences. ARAP1 displayed a clear substrate preference for ARF1 and ARF5 in vitro, whereas ARAP3 appeared to be specific for ARF6. Similarly, ARAP1 Rho GAP activity was directed primarily towards RhoA, while ARAP3 used RhoA, Rac1 or Cdc42 without preference [15, 16] .
Endogenous ARAP1 localized primarily to the Golgi complex, and could also be observed at the plasma membrane during cell spreading. Consistent with the idea that ARAP1 may regulate ARF1 function at the Golgi, overexpression of ARAP1 induced redistribution of some, but not all, Golgi markers, suggesting that the effects of ARAP1 were specific to subregions of the Golgi. ARAP1 also slowed reassembly of the Golgi after exposure to brefeldin A, a drug that inhibits ARF activation. These actions of ARAP1 at the Golgi required its ARF-GAP activity, but were independent of Rho-GAP function [15] . Overexpression of ARAP1 in NIH3T3 cells also affected the actin cytoskeleton, inducing a loss of stress fibers and cell rounding (which required Rho-GAP activity) and increased numbers of filopodia (which required ARF-GAP activity). Direct measurement of GTPase activation in transfected HEK293 cells revealed a two-fold increase in active Cdc42, consistent with the observed increase in filopodia. Surprisingly, however, no corresponding decrease in Rho activity was detected [15] . One plausible explanation for this is that the interaction of ARAP1 with RhoA may be highly localized, affecting only a small fraction of the total RhoA pool.
In contrast, ARAP3 did not localize to the Golgi, but was instead diffusely cytosolic in resting cells. Association of ARAP3 with the plasma membrane was enhanced by agents that increase cellular levels of PtdIns(3,4,5)P 3 , such as EGF and platelet-derived growth factor (PDGF). This translocation was inhibited by the phosphatidylinositol 3-kinase inhibitor wortmannin, suggesting that plasma membrane localization of this protein is mediated by direct binding to PtdIns(3,4,5)P 3 . Overexpression of ARAP3 in resting cells led to a reduction in the number of stress fibers, and a dramatic reduction in membrane ruffling induced by PDGF, which could be reversed by mutation of the amino-terminal PH domain, or simultaneous mutation of both ARF-GAP and Rho-GAP domains. Mutants lacking either ARF-GAP or Rho-GAP activity also inhibited membrane ruffling, but less potently than double mutants, suggesting that both ARF6 and a Rho family member (presumably Rac) act cooperatively in this process [16] . This is consistent with our recent observations that ARF6 and Rac function in a signaling cascade leading to the formation of lamellipodia in MDCK cells [14] .
Together, these observations suggest that the ARAPs can directly couple phosphoinositide signaling to both vesicular transport and organization of the actin cytoskeleton. However, numerous questions remain to be answered. What is the substrate specificity of these proteins in vivo? Why so many PH domains, and what role does each play in ARAP function? Does the Rho-GAP domain of ARAP1 function in any aspect of Golgi transport? Does ARAP2 serve as a Rho effector rather than a GAP? These two reports provide a solid foundation from which to pursue the answers to such questions. 
